(Q38981330)

8 September 2017

title

Suppression of toll-like receptor 2 expression inhibits the bioactivity of human hepatocellular carcinoma (English)

1 reference

8 September 2017

0 references

Wenna Shi

1

1 reference

8 September 2017

Lihui Su

2

1 reference

8 September 2017

Qianqian Li

3

1 reference

8 September 2017

Lidan Sun

4

1 reference

8 September 2017

Jing Lv

5

1 reference

8 September 2017

Jun Li

6

1 reference

8 September 2017

Baoquan Cheng

7

1 reference

8 September 2017

publication date

27 June 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

10

1 reference

8 September 2017

page(s)

9627-9637

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-014-2268-3

8 September 2017

exact match

0 references

cites work

A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

The promises and pitfalls of RNA-interference-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Listeria monocytogenes promotes tumor growth via tumor cell toll-like receptor 2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Intracellular expression of toll-like receptor 4 in neuroblastoma cells and their unresponsiveness to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Human lung cancer cells express functionally active Toll-like receptor 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

TLR3 can directly trigger apoptosis in human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

High mobility group box-1 is phosphorylated by protein kinase C zeta and secreted in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Toll-like receptors, inflammation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Reduced high-mobility group box 1 expression induced by RNA interference inhibits the bioactivity of hepatocellular carcinoma cell line HCCLM3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2268-3

Serum high mobility group box chromosomal protein 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Toll-like receptors as novel therapeutic targets for ovarian cancer

1 reference

12 December 2020

The expression of HMGB1 protein and its receptor RAGE in human malignant tumors

1 reference

12 December 2020

Toll-like receptor signalling

1 reference

12 December 2020

Life after death: targeting high mobility group box 1 in emergent cancer therapies

1 reference

12 December 2020

10.1007/S13277-014-2268-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1043547871

0 references

1 reference